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Natural killer (NK)-cell killing of virus-infected cells is regulated in part by the engagement of activation and
coactivation receptors. In this issue ofCell Host &Microbe, Shah et al. (2010) demonstrate that HIV-1 protects
infected cells from NK-cell-mediated killing by hindering NK-cell degranulation through downmodulation of
NTB-A coactivation receptor ligands by the Vpu accessory protein.Natural killer (NK) cells are a key compo-
nent of the innate immune system, given
their ability to lyse target cells and to
serve as an early source of immunoregu-
latory cytokines. Hence, they play an
important role in immune surveillance
and defense against viruses before the
emergence of virus-specific adaptive
immune responses (Lanier, 2008). NK-
cell function is regulated by a wide range
of receptors, activating or inhibitory, ex-
pressed at the surface of NK cells.
Ligands for these receptors may be pre-
sent on target cells. A broadly accepted
view is that integration of the intracellular
signals originating from these receptors
during target cell recognition determines
whether a NK cell will eliminate a poten-
tial target (Bryceson et al., 2006). NKG2D
is a potent NK-cell activation receptor
that recognizes genotoxic stress-induced
molecules, such as ULBP-1 and -2, as
ligands at the surface of target cells.
Although activation of NK receptors is
necessary for NK-cell-mediated cell lysis
of target cells, they are insufficient to
induce the production of lytic granules in
resting NK cells—a process designated
as degranulation—and, indeed, require
the concomitant triggering of coactivation
receptors (Bryceson et al., 2006). One
such factor that regulates NK-cell cytol-
ysis is the NK-T and B cell antigen
(NTB-A) coactivator receptor. NTB-A is a
member of the signaling lymphocytic acti-
vation molecule (SLAM) family of recep-
tors. It is a type 1 transmembrane protein
of the immunoglobulin superfamily that
functions as a homotypic ligand-coacti-
vation NK receptor pair.
Previous studies showed that HIV-1
infection leads to a decrease in surface
expression of HLA-A and -B inhibitory
ligands through the action of the Nef viralprotein (Cohen et al., 1999) and an
increase of NKG2D activating ligands
through the action of HIV-1 Vpr (Richard
et al., 2010; Ward et al., 2009). This repre-
sents a configuration that should make
HIV-1-infected cells optimal targets for
NK-cell-mediated destruction. However,
NK-cell-mediated killing of autologous
primary CD4+ T cells infected with HIV-1
was reported to be modest at best (Bona-
parte and Barker, 2003). In this issue of
Cell Host & Microbe, Shah et al. (2010)
provide an explanation for the inefficient
NK-cell-mediated killing of HIV-1-infected
cells. They report that the HIV-1 Vpu
accessory protein interferes with NK-
cell degranulation by downmodulating
NTB-A at the cell surface of infected cells.
A defining feature of primary immuno-
deficiency viruses is their ability to encode
a set of viral proteins—the so-called
accessory proteins—which include Vif,
Vpr, Vpu, and Nef in the case of HIV-1
(Kirchhoff, 2010). Overall, these proteins
act as adaptors and recruit fundamental
host cell machineries to create a cellular
environment that is favorable for viral per-
sistence, replication, transmission, dis-
semination, and immune evasion. HIV-1
Vpu is a type 1 membrane-associated
protein that is unique to HIV-1 and some
simian immunodeficiency viruses (SIVs)
(Kirchhoff, 2010). The protein was found
to contribute to HIV-1-induced downmo-
dulation of the CD4 receptor by mediating
a rapid degradation of receptor molecules
in the endoplasmic reticulum via the ubiq-
uitin-proteasome system. A key process
in Vpu-mediated CD4 degradation is the
recruitment of b-TrCP, a component of
the SCF (b-TrCP) E3 ubiquitin ligase and
the trans-ubiquitination of acceptor resi-
dues in the cytosolic tail of CD4. In addi-
tion to its effect on CD4 catabolism, VpuCell Host & Microbe 8, Npromotes the release of assembled
virions by antagonizing Tetherin (also
called BST2), an interferon-induced anti-
viral host protein (also called a restriction
factor) that directly crosslinks HIV-1
virions on the host cell surface (Figure 1).
Tetherin antagonism by Vpu is species
specificandcorrelateswith thedownregu-
lation of Tetherin at the cell surface. The
mechanism by which Vpu downregulates
Tetherin and promotes efficient release
of HIV-1 virions has recently attracted
considerable attention (Kirchhoff, 2010).
The emerging conscensus is that Vpu
associates with Tetherin via transmem-
brane domain (TMD) interactions and
sequesters the restriction factor in a peri-
nuclear compartment that costains with
trans-Golgi markers prior to targeting it
for lysosomal degradation in a b-TrCP-
dependent manner.
The study of Barker and colleagues
(Shah et al., 2010) now reveals that
Vpu, alone, can target another mem-
brane-associated protein, NTB-A, and
downregulate its levels at the surface of
HIV-1-infected cells (Figure 1). NTB-A
downmodulation by Vpu was found to
be mechanistically distinct from CD4
and Tetherin downmodulation, since Vpu
did not alter the steady-state levels of
NTB-A and did not rely on the recruitment
of b-TrCP to reduce cell surface NTB-A
levels. Although Vpu did not increase
NTB-A endocytosis as a mean to deplete
the coactivation NK receptor ligand from
the cell surface, the viral protein was
shown to interact with NTB-A through its
TMD, and the Vpu TMD was found to be
required for NTB-A downmodulation.
Together, these results suggest that
Vpu might downmodulate NTB-A through
an alteration of the trafficking and/or
recycling of the protein and as suchovember 18, 2010 ª2010 Elsevier Inc. 389
Figure 1. HIV-1 Vpu Interferes with the Activity of Several Host Cell Surface Factors Involved in Innate Immunity
Expression of HIV-1 Vpu in infected cells leads to the cell-surface downmodulation of Tetherin, CD1d, and NTB-A. By decreasing Tetherin levels at the cell
surface, Vpu prevents tethering of mature viruses to the plasma membrane of infected cells. Downmodulation of CD1d prevents presentation of lipid antigens
to CD1d-restricted NKT cells, thereby avoiding their activation. Finally, Vpu protects infected cells from NK-cell-mediated killing by downmodulating NTB-A,
since both NTB-A- and NKG2D-triggered signals are required for NK-cell degranulation. Overall, these Vpu activities reduce the efficiency of the innate immune
response directed against HIV-1-infected cells.
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compartment. In that regard, it is inter-
esting to note that downmodulation of
NTB-A by Vpu shares several similarities
with a recently reported activity of HIV-1
Vpu, that is, the inhibition of surface
expression of CD1d, amembrane-associ-
ated protein expressed by antigen-pre-
senting cells (APCs) such as monocytes,
macrophages, and dendritic cells (DCs)
(Moll et al., 2010). CD1d is involved in pre-
senting exogenous pathogen-derived
lipid antigens to CD1d-restricted natural
killer T (NKT) cells expressing an invariant
ab T cell receptor, thus resulting in the
mutual activation of both APC and NKT-
cells and the subsequent activation of
a cellular immune reponse (Figure 1). As
observed with NTB-A, Vpu did not
enhance constitutive CD1d endocytosis
or induce rapid CD1d degradation.
Instead, Vpu was found to interact with
CD1d and suppress its recycling from
endosomal compartments to the cell
surface by retaining CD1d in intracellular
compartments that included early endo-
somes. Importantly, this interference
with the CD1d antigen presentation
pathway strongly inhibited the ability of in-
fected DC to activate CD1d-restricted390 Cell Host & Microbe 8, November 18, 201NKT cells. The fact that Vpu is now
reported to target three membrane-asso-
ciated cell-surface proteins involved in
various aspects of the innate immune
response raises the possibility that Vpu
may be a key factor used by HIV-1 to
evade innate immunity (Figure 1).
The results presented by Barker and
colleagues (Shah et al., 2010) raise many
new questions about the interaction of
Vpu and NTB-A. One important future
goal will be to assess precisely how Vpu
downmodulates NTB-A levels at the cell
surface of infected cells. Furthermore,
given that the Vpu TMD is involved in
complex formation with Tetherin, and
NTB-A, two proteins sharing little se-
quence homology, it remains unclear
how the specific recognition of Tetherin
and NTB-A by Vpu is governed and how
can Vpu control both host proteins
simultaneously.
Another important result from the Shah
et al. (2010) study is that NTB-A engage-
ment is required for NK cells to degranu-
late when the activation receptor NKG2D
is triggered, thus establishing an activa-
tion/coactivation receptor pair that may
be functional during HIV-1 infection. Inter-
estingly, although HIV-1-infected cells0 ª2010 Elsevier Inc.induced vigourous NKG2D-dependent
activation of NK-cells, they failed to
trigger efficient degranulation (Figure 1).
Indeed, Vpu-mediated downmodulation
of NTB-A was found to hinder NK-cell
degranulation, thus ultimately protecting
infected cell from NK-cell-mediated lysis.
While Vpu may in part protect HIV-1-
infected cells from NK-cell-mediated
lysis, it will be important to assess the
implication of the sustained activation of
NK cells via NKG2D on the function of
NK cells. Indeed, accumulating evidence
indicates that NK-cell function is compro-
mised during HIV-1 infection through
poorly understood mechanisms (Alter
and Altfeld, 2006). The fact that the emer-
gence of a novel subset of NK cells that
lacks the majority of NK-cell functions
directly correlates with viral load suggests
that the presence of viral antigens has
a role in NK-cell dysfunction. Hence,
HIV-1 might employ a dual strategy to
interfere with NK-cell function; early in
infection, HIV-1 might interfere specifi-
cally with NK-cell degranulation through
the action of Vpu as a mean to protect
infected cells from NK-cell-mediated
killing, whereas the sustained activation
of NK cell triggered by Vpr might impede
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chronic phase of infection. Clearly, the
study by Shah et al. (2010) marks only
the beginning of a fascinating story that
will shed new light on an important but still
poorly understood aspect of the interac-
tion of HIV-1 with NK cells.
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Intracellular bacterial pathogens engage in a tug-of-war with innate host defenses. In this issue ofCell Host &
Microbe, Mostowy et al. (2010) identify a role for the septin family of cytoskeletal proteins in targeting intra-
cellular Shigella to the autophagy pathway.Several pathogenic bacteria, including
Listeria monocytogenes, Salmonella
spp., Legionella pneumophila, Yersinia
spp., and Shigella spp., cause disease
by entering into and surviving within cells.
These intracellular bacteria engage in
a tug-of-warwith host cell defenses, being
pulled between bacterial restriction and
death on one side and dissemination
and survival on the other. In the time
immediately after infection, the former is
mediated to a large extent by the host
cell autophagy pathway. In this pathway,
intracellular bacteria are engulfed in intra-
cytosolic membrane-bound vacuoles
called autophagosomes that fuse with
lysosomes, leading to bacterial destruc-
tion (Deretic and Levine, 2009). Shigella
spp. are among a subset of intracellular
bacterial pathogens that, after entry into
cells, escape the vacuole and replicate in
the cytosol. Once in the cytosol, each
member of this group, which includes
Shigella spp., L. monocytogenes, Bur-
kholderia spp., Rickettsia spp., and
Mycobacterium marinum, induces actin
polymerization on its surface, whichpropels it to the cell periphery, whereupon
it spreads into adjacent cells (Stevens
et al., 2006). The ability of these organisms
to spread directly into adjacent cells is
critical to virulence. Of the population
of organisms that enter the cytosol in a
given infection, a substantial percentage
escape autophagy, while others are
brought into the autophagy pathway
where they are destroyed (Ogawa et al.,
2005). The intracellular fate of these cyto-
solic bacteria is a delicate balance
between bacterial and host factors. For
Shigella, autophagy proteins bind the
bacterial protein IcsA (VirG), which is
required for actin-based motility, and this
interaction is inhibited by a second bacte-
rial protein, IcsB (Ogawa et al., 2005). Few
host factors that determine the fate of
intracellular Shigella have been previously
identified. In this issue, Mostowy et al.
(2010) demonstrate a role for the host
septin family of cytoskeletal proteins in
targeting intracytosolic Shigella flexneri
to the autophagy pathway.
Septins are a large class of proteins
involved in many diverse cellular pro-cesses that have been shown to function-
ally interact with cellular membranes and
the cytoskeleton. Originally discovered in
1971 through a genetic screen for yeast
mutants defective in budding, septins
assemble into rings at the yeast bud
neck and are thought to act as membrane
diffusion barriers that separate themother
from the daughter cell (Cao et al., 2009).
Septins are conserved across animals
and fungi, but are absent in plants. Hu-
mans have 14 septins that are divided
into four groups, among which there is
partial functional redundancy. Impor-
tantly, septins from the different groups
form hetero-oligomeric protein com-
plexes that assemble into nonpolar fila-
ments (Weirich et al., 2008). The variation
in septin proteins and their ability to form
higher order hetero-oligomeric structures
translates into many combinatorial possi-
bilities, leading to distribution throughout
the cell and multiple diverse protein inter-
actions and functions.
Several notable functions of septins
relate to their ability to interact with
membranes. In addition to serving asovember 18, 2010 ª2010 Elsevier Inc. 391
